Identification of a Novel Susceptibility Locus at 13q34 and Refinement of the 20p12.2 Region As a Multi-Signal Locus Associated with Bladder Cancer Risk in Individuals of European Ancestry.
Jonine D Figueroa,Candace D Middlebrooks,A Rouf Banday,Yuanqing Ye,Montserrat Garcia-Closas,Nilanjan Chatterjee,Stella Koutros,Lambertus A Kiemeney,Thorunn Rafnar,Timothy Bishop,Helena Furberg,Giuseppe Matullo,Klaus Golka,Manuela Gago-Dominguez,Jack A Taylor,Tony Fletcher,Afshan Siddiq,Victoria K Cortessis,Charles Kooperberg,Olivier Cussenot,Simone Benhamou,Jennifer Prescott,Stefano Porru,Colin P Dinney,Núria Malats,Dalsu Baris,Mark P Purdue,Eric J Jacobs,Demetrius Albanes,Zhaoming Wang,Charles C Chung,Sita H Vermeulen,Katja K Aben,Tessel E Galesloot,Gudmar Thorleifsson,Patrick Sulem,Kari Stefansson,Anne E Kiltie,Mark Harland,Mark Teo,Kenneth Offit,Joseph Vijai,Dean Bajorin,Ryan Kopp,Giovanni Fiorito,Simonetta Guarrera,Carlotta Sacerdote,Silvia Selinski,Jan G Hengstler,Holger Gerullis,Daniel Ovsiannikov,Meinolf Blaszkewicz,Jose Esteban Castelao,Manuel Calaza,Maria Elena Martinez,Patricia Cordeiro,Zongli Xu,Vijayalakshmi Panduri,Rajiv Kumar,Eugene Gurzau,Kvetoslava Koppova,H Bas Bueno-De-Mesquita,Börje Ljungberg,Françoise Clavel-Chapelon,Elisabete Weiderpass,Vittorio Krogh,Miren Dorronsoro,Ruth C Travis,Anne Tjønneland,Paul Brennan,Jenny Chang-Claude,Elio Riboli,David Conti,Marianna C Stern,Malcolm C Pike,David Van Den Berg,Jian-Min Yuan,Chancellor Hohensee,Rebecca P Jeppson,Geraldine Cancel-Tassin,Morgan Roupret,Eva Comperat,Constance Turman,Immaculata De Vivo,Edward Giovannucci,David J Hunter,Peter Kraft,Sara Lindstrom,Angela Carta,Sofia Pavanello,Cecilia Arici,Giuseppe Mastrangelo,Ashish M Kamat,Liren Zhang,Yilei Gong,Xia Pu,Amy Hutchinson,Laurie Burdett,William A Wheeler,Margaret R Karagas,Alison Johnson,Alan Schned,G M Monawar Hosain,Molly Schwenn,Manolis Kogevinas,Adonina Tardón,Consol Serra,Alfredo Carrato,Reina García-Closas,Josep Lloreta,Gerald Andriole,Robert Grubb,Amanda Black,W Ryan Diver,Susan M Gapstur,Stephanie Weinstein,Jarmo Virtamo,Christopher A Haiman,Maria Teresa Landi,Neil E Caporaso,Joseph F Fraumeni,Paolo Vineis,Xifeng Wu,Stephen J Chanock,Debra T Silverman,Ludmila Prokunina-Olsson,Nathaniel Rothman
DOI: https://doi.org/10.1093/hmg/ddv492
IF: 5.1214
2016-01-01
Human Molecular Genetics
Abstract:Candidate gene and genome-wide association studies (GWAS) have identified 15 independent genomic regions associated with bladder cancer risk. In search for additional susceptibility variants, we followed up on four promising single-nucleotide polymorphisms (SNPs) that had not achieved genome-wide significance in 6911 cases and 11 814 controls (rs6104690, rs4510656, rs5003154 and rs4907479, P < 1 × 10(-6)), using additional data from existing GWAS datasets and targeted genotyping for studies that did not have GWAS data. In a combined analysis, which included data on up to 15 058 cases and 286 270 controls, two SNPs achieved genome-wide statistical significance: rs6104690 in a gene desert at 20p12.2 (P = 2.19 × 10(-11)) and rs4907479 within the MCF2L gene at 13q34 (P = 3.3 × 10(-10)). Imputation and fine-mapping analyses were performed in these two regions for a subset of 5551 bladder cancer cases and 10 242 controls. Analyses at the 13q34 region suggest a single signal marked by rs4907479. In contrast, we detected two signals in the 20p12.2 region-the first signal is marked by rs6104690, and the second signal is marked by two moderately correlated SNPs (r(2) = 0.53), rs6108803 and the previously reported rs62185668. The second 20p12.2 signal is more strongly associated with the risk of muscle-invasive (T2-T4 stage) compared with non-muscle-invasive (Ta, T1 stage) bladder cancer (case-case P ≤ 0.02 for both rs62185668 and rs6108803). Functional analyses are needed to explore the biological mechanisms underlying these novel genetic associations with risk for bladder cancer.